{"version":"1.0","provider_name":"Leitat Technological Center","provider_url":"https:\/\/leitat.org\/es\/","author_name":"Comunicaci\u00f3n Leitat","author_url":"https:\/\/leitat.org\/es\/blog\/author\/comunica-wp\/","title":"NANONAFRES - Leitat Technological Center","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1XkDY60h3d\"><a href=\"https:\/\/leitat.org\/es\/blog\/nanonafres\/\">NANONAFRES<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/leitat.org\/es\/blog\/nanonafres\/embed\/#?secret=1XkDY60h3d\" width=\"600\" height=\"338\" title=\"\u00abNANONAFRES\u00bb \u2014 Leitat Technological Center\" data-secret=\"1XkDY60h3d\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/leitat.org\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/leitat.org\/wp-content\/uploads\/2016\/09\/nanonafres-imatge-7176805c.jpeg","thumbnail_width":656,"thumbnail_height":379,"description":"NANONAFRES Preclinical and Clinical Studies of Nanovesicles (Quatsomes) with EGF for Chronic Venous Ulcers Objective: Conduct preclinical studies and clinical trials to evaluate the application of nanovesicles containing epidermal growth factor (EGF) administered topically to patients with chronic venous ulcers. The goal is to facilitate epithelialization and ulcer closure. Innovation: Development of an innovative vehicle [&hellip;]"}